Key facts
- This page summarizes R. Michael Carruthers's Form 3 filing for OnKure Therapeutics, Inc. (OKUR).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 Oct 2024, 19:07.
R. Michael Carruthers - 04 Oct 2024 Form 3 Insider Report for OnKure Therapeutics, Inc. (OKUR)
- Reporting relationship
- Director
- Issuer ticker
- OKUR
- Reported as of
- 04 Oct 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 08 Oct 2024, 19:07:51 UTC
- Prior SEC filing
- 24 Sep 2024
- Next SEC filing
- 16 Oct 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Rogan Nunn, by power of attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
R. Michael Carruthers filed Form 3 for OnKure Therapeutics, Inc. (OKUR) on 08 Oct 2024.
Change
- Previous filing in this sequence was filed on 24 Sep 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.